Dymista Spray, Metered
NDC Package 0037-0245-23
Package Information
Dymista (azelastine hydrochloride and fluticasone propionate) sprays is a medication used to relieve seasonal allergy symptoms of the nose such as stuffy/runny nose, itching, sneezing, and post-nasal drip. This formulation utilizes a spray, metered delivery system. Marketed by Viatris Specialty Llc, this product is identified by NDC 0037-0245 and is authorized under FDA application NDA202236.
Identification & Billing
- RxCUI: 1797847 - azelastine HCl 137 MCG/ACTUAT / fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
- RxCUI: 1797847 - azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray
- RxCUI: 1797849 - Dymista 137/50 MCG/ACTUAT Metered Dose Nasal Spray
- RxCUI: 1797849 - azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Dymista]
- RxCUI: 1797849 - Dymista (azelastine hydrochloride 137 MCG/ACTUAT / fluticasone propionate 50 MCG/ACTUAT) Metered Dose Nasal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0037 - Viatris Specialty Llc
- 0037-0245 - Dymista
- 0037-0245-23 - 1 BOTTLE, SPRAY in 1 BOX / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
- 0037-0245 - Dymista
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0037-0245-23 identifies a specific commercial package of 1 bottle, spray in 1 box / 120 spray, metered in 1 bottle, spray of Dymista, a human prescription drug labeled by Viatris Specialty Llc. This spray, metered is formulated for nasal use and contains azelastine hydrochloride; fluticasone propionate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Viatris Specialty Llc on October 01, 2016. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to relieve seasonal allergy symptoms of the nose such as stuffy/runny nose, itching, sneezing, and post-nasal drip. It contains 2 drugs. Azelastine is an antihistamine that works by blocking certain natural substances called histamines that are responsible for allergic symptoms. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.
How is this Viatris Specialty Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00037024523. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.